Multiplex real-time PCR FilmArray performance in the diagnosis of meningoencephalitis: lights and shadows.

Publication Year: 2023

DOI:
10.1007/s15010-023-02076-x

PMCID:
PMC10810907

PMID:
37515691

Journal Information

Full Title: Infection

Abbreviation: Infection

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Competing interestsThe authors declare no competing interests. Conflict of interestCG-V has received honoraria for talks on behalf of Gilead Science, Merck Sharp and Dohme, Pfizer, Jannsen, Novartis, Lilly and a grant support from Gilead Science and Merck Sharp and Dohme. AS has received honoraria for lectures and advisory boards from Pfizer, Merck Sharp and Dohme, Shionogi, Angelini, Menarini, and Gilead Sciences. AS has received grants from Pfizer and Gilead Sciences. P.P.-A. has received honoraria for talks on behalf of Merck Sharp and Dohme, Lilly, ViiV Healthcare and Gilead Science. P.P.-A. has participated in advisory boards for Gilead Science. Competing interests The authors declare no competing interests. Conflict of interest CG-V has received honoraria for talks on behalf of Gilead Science, Merck Sharp and Dohme, Pfizer, Jannsen, Novartis, Lilly and a grant support from Gilead Science and Merck Sharp and Dohme. AS has received honoraria for lectures and advisory boards from Pfizer, Merck Sharp and Dohme, Shionogi, Angelini, Menarini, and Gilead Sciences. AS has received grants from Pfizer and Gilead Sciences. P.P.-A. has received honoraria for talks on behalf of Merck Sharp and Dohme, Lilly, ViiV Healthcare and Gilead Science. P.P.-A. has participated in advisory boards for Gilead Science."

Evidence found in paper:

"Funding Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. P.P.-A. (JR20/00012, PI21/00498, and ICI21/00103) and C.G.-V. (FIS PI21/01640 and ICI21/00103) have received research grants funded by Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union. The funders had neither a specific role in study design or collection of data, nor in writing of the paper or decision to submit."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025